{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:24:14Z","timestamp":1771003454378,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1994,7,1]],"date-time":"1994-07-01T00:00:00Z","timestamp":773020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1994,7]]},"DOI":"10.1007\/bf01757351","type":"journal-article","created":{"date-parts":[[2005,6,15]],"date-time":"2005-06-15T17:40:03Z","timestamp":1118857203000},"page":"S25-S29","source":"Crossref","is-referenced-by-count":11,"title":["Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes \u2014 first experience with their reversal"],"prefix":"10.1007","volume":"69","author":[{"given":"V.","family":"N\u00fcssler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pelka-Fleischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Zwierzina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Nerl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Beckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gullis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gieseler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bartl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. E.","family":"Petrides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Wilmanns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01757351_CR1","first-page":"310","volume":"53","author":"RJ Arcei","year":"1993","unstructured":"Arcei RJ, Stieglitz K, Bras J, Schinkel A, Baas F, Croop J (1993) Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein. Cancer Res 53:310\u2013317","journal-title":"Cancer Res"},{"key":"BF01757351_CR2","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1182\/blood.V79.12.3267.3267","volume":"79","author":"E Berman","year":"1992","unstructured":"Berman E, McBride M (1992) Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cells. Blod 79:3267\u20133273","journal-title":"Blod"},{"key":"BF01757351_CR3","first-page":"777","volume":"319","author":"G Carulli","year":"1988","unstructured":"Carulli G, Petrini M, Marini A, Ambrogi F (1988) P-glycoprotein in acute lymphoblastic leukemia and in the blastic crisis of myeloid leukemia. N Engl J Med 319:777\u2013780","journal-title":"N Engl J Med"},{"key":"BF01757351_CR4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/bjc.1992.309","volume":"66","author":"AR Dixon","year":"1992","unstructured":"Dixon AR, Bell J, Ellis IO, Elston CW, Blarney RW (1992) P-Glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy. Br J Cancer 66:537\u2013541","journal-title":"Br J Cancer"},{"key":"BF01757351_CR5","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1177\/39.12.1682363","volume":"39","author":"CL Finstad","year":"1991","unstructured":"Finstad CL, Yin BWT, Gordon CM, Federici MG, Welt S, Lloyd KO (1991) Some monoclonal antibody reagents (C219 and JSB-1) to P-glycoprotein contain antibodies to blood group-A carbohydrate determinants: a problem of quality control for immunohistochemical analysis. J Histochem Cytochem 39:1603\u20131610","journal-title":"J Histochem Cytochem"},{"key":"BF01757351_CR6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/81.2.116","volume":"81","author":"LJ Goldstein","year":"1989","unstructured":"Goldstein LJ, Oalski H, Fojo A et al. (1989) Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81:116\u2013124","journal-title":"J Natl Cancer Inst"},{"key":"BF01757351_CR7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1073\/pnas.83.2.337","volume":"83","author":"P Gros","year":"1986","unstructured":"Gros P, Croop J, Roninson I, Varshavasky A, Houseman D (1986) Isolation and charcterization of DNA sequences amplified in multidrug-resistant hamster cells. Proc Natl Acad Sci USA 83:337\u2013341","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01757351_CR8","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1073\/pnas.83.20.7785","volume":"83","author":"H Hamada","year":"1986","unstructured":"Hamada H, Tsuruo T (1986) Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci USA 83:7785\u20137789","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01757351_CR9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF01294440","volume":"118","author":"J Hofmann","year":"1992","unstructured":"Hofmann J, Wolf A, Spitaler M, B\u00f6ck G, Drach J, Ludescher C, Grunicke H (1992) Reversal of multidrug resistance by B859-35, a metabolite of B859-35, nigulgipine, verapamil and nitrendipine. J Cancer Res Clin Oncol 118:361\u2013366","journal-title":"J Cancer Res Clin Oncol"},{"key":"BF01757351_CR10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2141.1989.tb07649.x","volume":"72","author":"J Holmes","year":"1989","unstructured":"Holmes J, Jacobs A, Carter G, Janowska-Wieczoreck A, Padua RA (1989) Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukemia. Br J Haematol 72:40\u201344","journal-title":"Br J Haematol"},{"key":"BF01757351_CR11","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/316820a0","volume":"316","author":"N Kartner","year":"1985","unstructured":"Kartner N, Evernden-Porelle D, Bradley G, Ling V (1985) Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 316:820\u2013823","journal-title":"Nature"},{"key":"BF01757351_CR12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.1990.tb02533.x","volume":"74","author":"Y Kuwarazuru","year":"1990","unstructured":"Kuwarazuru Y, Yoshimura A, Hanada S et al. (1990) Expression of the multidrug transporter, P-glycoprotein, in chronic myelogenous leukemia cells in blast crisis. Br J Haematol 74:24\u201329","journal-title":"Br J Haematol"},{"key":"BF01757351_CR13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2141.1991.tb04378.x","volume":"78","author":"AF List","year":"1991","unstructured":"List AF, Spier CM, Cline A, Doll DC, Garewal H, Morgan R, Avery A (1991) Expression of the multidrug-resistance gene product (P-glycoprotein) in myelodysplasia is associated with a stem cell phenotype. Br J haematol 78:28\u201334","journal-title":"Br J haematol"},{"key":"BF01757351_CR14","unstructured":"Nuessler V, Gieseler F, Pelka-Fleischer R, Zwierzina H, Gullis E, Abenhardt W, Schmitt R, Langenmayer I, Heinemann V, Kolb HJ, Wilmanns W (1994) Idarubicin monotherapy in multiply pretreated leukemia patients: response in relation to P-Glycoprotein expression (submitted)"},{"key":"BF01757351_CR15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0145-2126(93)90015-D","volume":"17","author":"P Reizenstein","year":"1993","unstructured":"Reizenstein P (1993) Resistance-modifying agents are active in some patients with hematological malignancy. Leuk Res 17:295\u2013298","journal-title":"Leuk Res"},{"key":"BF01757351_CR16","first-page":"2628","volume":"51","author":"AH Schinkel","year":"1991","unstructured":"Schinkel AH, Roelofs MEM, Borst P (1991) Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Cancer Res 51:2628\u20132635","journal-title":"Cancer Res"},{"key":"BF01757351_CR17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/jnr.490280218","volume":"28","author":"HJ Schluesener","year":"1991","unstructured":"Schluesener HJ (1991) Multidrug transport in human glioblastoma cells is inhibited by transforming growth factors type\u0392 1 \u0392 2,\u0392 1,2. J Neurosci Res 28:310\u2013314","journal-title":"J Neurosci Res"},{"key":"BF01757351_CR18","first-page":"5821","volume":"51","author":"F \u00fcberall","year":"1991","unstructured":"\u00fcberall F, Maly K, Egle A, Doppler W, Hofmann J, Grunicke H (1991) Inhibition of cell proliferation, protein kinase C, and phorbol ester-induced fos expression by the dihydropyridine derivative B859-35. Cancer Res 51:5821\u20135825","journal-title":"Cancer Res"},{"key":"BF01757351_CR19","first-page":"695","volume":"4","author":"R Weide","year":"1990","unstructured":"Weide R, Dowding C, Paulsen W, Goldman J (1990) The role of the mdr-1\/P-170 mechanism in the development of multidrug resistance in chronic myeloid leukemia. Leukemia 4:695\u2013699","journal-title":"Leukemia"},{"key":"BF01757351_CR20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-3835(93)90166-7","volume":"69","author":"A Wilisch","year":"1993","unstructured":"Wilisch A, Noller A, Handgretinger R, Weger S, N\u00fcssler V, Niethammer D, Probst H (1993) Mdr1\/P-Glycoprotein expression in natural killer (NK) cells enriched from peripheral or umbilical cord blood. Cancer Lett 69:139\u2013148","journal-title":"Cancer Lett"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01757351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01757351\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01757351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T19:10:02Z","timestamp":1586286602000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01757351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,7]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,7]]}},"alternative-id":["BF01757351"],"URL":"https:\/\/doi.org\/10.1007\/bf01757351","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,7]]}}}